| CAT No: | CL-EVC-01 |
| CAS No: | NA |
| Mol.F: | C27H28D3FN4O8 |
| Mol.Wt.: | 561.6 |
| Chemical Name: | (4S,4aS,5aR,12aS)-7-fluoro-3,10,12,12a-tetrahydroxy-4-(methyl(methyl-d3)amino)-1,11-dioxo-9-(2-(pyrrolidin-1-yl)acetamido)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide |
| Inventory Status: | Custom synthesis |
This impurity is related to Eravacycline d3 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Eravacycline d3 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(4S,4aS,5aR,12aS)-7-fluoro-3,10,12,12a-tetrahydroxy-4-(methyl(methyl-d3)amino)-1,11-dioxo-9-(2-(pyrrolidin-1-yl)acetamido)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Eravacycline Molecular Formula: C27H28D3FN4O8
Molecular Weight: 561.6
Storage: Store in a cool, dry place.
| Product Name: | Eravacycline d3 |
| CAS No: | |
| Mol.F.: | C27H28D3FN4O8 |
| Mol.Wt.: | 561.6 |
Cat. No: CL-EVC-NO-001
CAS No: NA
Mol. F: C27H30FN5O9
Mol. Wt: 587.6
Inv. Status: Custom Synthesis
Cat. No: CL-EVC-NO-002
CAS No: NA
Mol. F: C26H28FN5O9
Mol. Wt: 573.5
Inv. Status: Custom Synthesis
Cat. No: CL-EVC-02
CAS No: NA
Mol. F: C27H25D6FN4O8
Mol. Wt: 564.6
Inv. Status: Custom Synthesis
Cat. No: CL-EVC-03
CAS No: NA
Mol. F: C27H23D8FN4O8
Mol. Wt: 566.6
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: